David Crawford

3.7k total citations · 2 hit papers
45 papers, 2.4k citations indexed

About

David Crawford is a scholar working on Pulmonary and Respiratory Medicine, Astronomy and Astrophysics and Oncology. According to data from OpenAlex, David Crawford has authored 45 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 8 papers in Astronomy and Astrophysics and 8 papers in Oncology. Recurrent topics in David Crawford's work include Prostate Cancer Treatment and Research (16 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Lightning and Electromagnetic Phenomena (8 papers). David Crawford is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Lightning and Electromagnetic Phenomena (8 papers). David Crawford collaborates with scholars based in United States, Sweden and United Kingdom. David Crawford's co-authors include Edward M. Messing, Judith Manola, Maureen Kiernan, Donald L. Trump, George Wilding, P. Anthony diSant’Agnese, Jorge L. Yao, Richard Sylvester, S. Krege and Per‐Uno Malmström and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Geophysical Research Atmospheres and Child Development.

In The Last Decade

David Crawford

43 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy

2006 624 citations Edward M. Messing, Judith Manola et al. The Lancet Oncology profile →
An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

2009 465 citations Per‐Uno Malmström, Richard Sylvester et al. European Urology profile →

Peers

David Crawford

PRM

SURGE

EDM

James M. Slater United States

Lawrence B. Levy United States

Philippe Mangin France

Charles Ludgate Canada

Jeffrey A. Stern United States

Christian Doll Germany

Christopher King United States

Hubert Thierens Belgium

Benjamin L. Franc United States

Jingfei Ma United States

James M. Slater United States

David Crawford

2.2k ×1.8

PRM

491 ×0.7

SURGE

16 ×0.0

104 ×0.4

EDM

204 ×0.7

Citations per year, relative to David Crawford David Crawford (= 1×) peers James M. Slater

Countries citing papers authored by David Crawford

Since Specialization

Citations

This map shows the geographic impact of David Crawford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Crawford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Crawford more than expected).

Fields of papers citing papers by David Crawford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Crawford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Crawford. The network helps show where David Crawford may publish in the future.

Co-authorship network of co-authors of David Crawford

This figure shows the co-authorship network connecting the top 25 collaborators of David Crawford. A scholar is included among the top collaborators of David Crawford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Crawford. David Crawford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nag, Amitabh, Kenneth L. Cummins, Robert G. Brown, et al.. (2023). Characteristics of upward-connecting-leader current leading to attachment in downward negative cloud-to-ground lightning strokes. Atmospheric Research. 294. 106943–106943. 2 indexed citations

Nag, Amitabh, Kenneth L. Cummins, David Crawford, et al.. (2020). Inferences on upward leader characteristics from measured currents. Atmospheric Research. 251. 105420–105420. 7 indexed citations

Patel, Nayana, Kimberly E. Lind, Kavita Garg, et al.. (2018). Assessment of PI-RADS v2 categories ≥ 3 for diagnosis of clinically significant prostate cancer. Abdominal Radiology. 44(2). 705–712. 20 indexed citations

Crawford, David, Zaina P. Qureshi, Nicole Mittmann, et al.. (2013). Estimating The Cost For Prostate Cancer (Pca) Screening Using The Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial Data. Value in Health. 16(3). A151–A151. 1 indexed citations

Khera, Mohit, David Crawford, Álvaro Morales, Andrea Salonia, & Abraham Morgentaler. (2013). A New Era of Testosterone and Prostate Cancer: From Physiology to Clinical Implications. European Urology. 65(1). 115–123. 121 indexed citations

Malmström, Per‐Uno, Richard Sylvester, David Crawford, et al.. (2009). An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer. European Urology. 56(2). 247–256. 465 indexed citations breakdown →

Veldhuizen, Peter J. Van, Michael A. Hussey, Primo N. Lara, et al.. (2009). A Phase II Study of Gemcitabine and Capecitabine in Patients With Advanced Renal Cell Cancer. American Journal of Clinical Oncology. 32(5). 453–459. 14 indexed citations

Laiyemo, Adeyinka O., Chyke A. Doubeni, Paul F. Pinsky, et al.. (2009). Race-Ethnicity and Colorectal Cancer Disparities: Is There a Difference in Adenoma Initiation? Evidence from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Gastrointestinal Endoscopy. 69(5). AB275–AB275. 1 indexed citations

Anderson, John, Per‐Anders Abrahamsson, David Crawford, Kurt Miller, & Bertrand Tombal. (2008). Management of advanced prostate cancer: can we improve on androgen deprivation therapy?. British Journal of Urology. 101(12). 1497–1501. 31 indexed citations

10.

Messing, Edward M., Judith Manola, Jorge L. Yao, et al.. (2006). Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. The Lancet Oncology. 7(6). 472–479. 624 indexed citations breakdown →

11.

Kang, Daehee, Gerald L. Andriole, David Crawford, et al.. (2004). Risk behaviours and benign prostatic hyperplasia. British Journal of Urology. 93(9). 1241–1245. 58 indexed citations

12.

Koul, Hari K., Paul Maroni, Randall B. Meacham, David Crawford, & Sweaty Koul. (2004). p42/p44 Mitogen‐Activated Protein Kinase Signal Transduction Pathway: A Novel Target for the Treatment of Hormone‐Resistant Prostate Cancer?. Annals of the New York Academy of Sciences. 1030(1). 243–252. 7 indexed citations

13.

Amato, R. J., et al.. (2004). Phase II study of CC-4047 in patients with metastatic hormone-refractory prostate cancer (HRPCa). Journal of Clinical Oncology. 22(14_suppl). 4701–4701. 1 indexed citations

14.

Messing, Edward M., Judith Manola, Michael Sarosdy, et al.. (2004). Immediate hormonal therapy versus observation after radical prostatectomy and pelvic lymphadenectomy for node positive prostate cancer: At 10 years results of EST3886. Journal of Clinical Oncology. 22(14_suppl). 4570–4570. 39 indexed citations

15.

Cramer, John A., Martin J. Murphy, David Crawford, Vladimir A. Rakov, & Kenneth L. Cummins. (2001). An Evaluation of the Performance Characteristics of the NLDN Using Triggered Lightning. AGU Fall Meeting Abstracts. 2001. 9 indexed citations

16.

Chan, Daniel W., Lori J. Sokoll, Alan W. Partin, et al.. (1999). THE USE OF % FREE PSA (%fPSA) TO PREDICT PROSTATE CANCER PROBABILITIES. The Journal of Urology. 95–95. 7 indexed citations

17.

Crawford, David, et al.. (1998). The Cold Fusion: Web Application Construction Kit: Second Edition. 3 indexed citations

18.

Crawford, David, et al.. (1996). Web Database Construction Kit with Cold Fusion 2.0, with CD-ROM. 1 indexed citations

19.

Crawford, David, et al.. (1977). The extended jones—dole equation. Electrochimica Acta. 22(10). 1183–1187. 22 indexed citations

20.

Ault, Ruth L., David Crawford, & Wendell E. Jeffrey. (1972). VISUAL SCANNING STRATEGIES OF REFLECTIVE, IMPULSIVE, FAST-ACCURATE, AND SLOW-INACCURATE CHILDREN ON THE MATCHING FAMILIAR FIGURES TEST. Child Development. 43(4). 1412–1417. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact